Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB06366
http://purl.obolibrary.org/obo/dinto_DB06366
|
|---|---|
| Preferred Name | pertuzumab |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | pertuzumab
|
|---|---|
| label | pertuzumab
|
| DBSynonym |
r1273
monoclonal antibody 2c4
omnitarg
2c4 antibody
rhumab-2c4
moab 2c4
See more
See less
|
| ATCCode | L01XC13
|
| Definition | Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). It consists of two heavy chains and two lights chains that have 448 and 214 residues respectively. FDA approved June 8, 2012.
|
| has pharmacological target | |
| type | |
| AHFScode | 10:00
|
| xref |
Wikipedia:http://en.wikipedia.org/wiki/Pertuzumab
Drugs.com:http://www.drugs.com/perjeta.html
RxList:www.rxlist.com/perjeta-drug.htm
National Drug Code Directory:50242-145-01
|
| CASRN | 380610-27-5
|
| prefixIRI | obo2:dinto_DB06366
|
| related with | |
| DBBrand | perjeta
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |